Search Results - "MASUR, Henry"

Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance by Strich, Jeffrey R, Heil, Emily L, Masur, Henry

“…Patients with sepsis present across a spectrum of infection sites and severity of illnesses requiring complex decision making at the bedside as to when prompt…”
Get full text

Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit by Murray, Patrick R, Masur, Henry

“…Healthcare systems spend considerable resources collecting and processing blood cultures for the detection of blood stream pathogens. The process is initiated…”
Get full text

Guidelines for the Prevention of Intravascular Catheter-related Infections by O'Grady, Naomi P., Alexander, Mary, Burns, Lillian A., Dellinger, E. Patchen, Garland, Jeffrey, Heard, Stephen O., Lipsett, Pamela A., Masur, Henry, Mermel, Leonard A., Pearson, Michele L., Raad, Issam I., Randolph, Adrienne G., Rupp, Mark E., Saint, Sanjay

Get full text

Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy by Sidharthan, Sreetha, Kohli, Anita, Sims, Zayani, Nelson, Amy, Osinusi, Anu, Masur, Henry, Kottilil, Shyam

“…Background. Hepatitis C virus (HCV) RNA loads serve as predictors of treatment response during interferon-based therapy. We evaluated the predictive ability of…”
Get full text

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients by Meissner, Eric G., Lee, Yu‐Jin, Osinusi, Anu, Sims, Zayani, Qin, Jing, Sturdevant, Dan, McHutchison, John, Subramanian, Mani, Sampson, Maureen, Naggie, Susanna, Patel, Keyur, Remaley, Alan T., Masur, Henry, Kottilil, Shyam

“…Hepatitis C virus (HCV) modulates intrahepatic cholesterol biosynthetic pathways to promote viral replication. Chronic HCV infection is associated with altered…”
Get full text

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study by Kohli, Anita, MD, Kapoor, Rama, MD, Sims, Zayani, BS, Nelson, Amy, RN, Sidharthan, Sreetha, BS, Lam, Brian, PA, Silk, Rachel, RN, Kotb, Colleen, NP, Gross, Chloe, RN, Teferi, Gebeyehu, MD, Sugarman, Kate, MD, Pang, Phillip S, MD, Osinusi, Anu, MD, Polis, Michael A, MD, Rustgi, Vinod, MD, Masur, Henry, MD, Kottilil, Shyam, Dr

“…Summary Background Worldwide, although predominantly in low-income countries in the Middle East and Africa, up to 13% of hepatitis C virus (HCV) infections are…”
Get full text

Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America by O’Grady, Naomi P, Barie, Philip S, Bartlett, John G, Bleck, Thomas, Carroll, Karen, Kalil, Andre C, Linden, Peter, Maki, Dennis G, Nierman, David, Pasculle, William, Masur, Henry

“…OBJECTIVE:To update the practice parameters for the evaluation of adult patients who develop a new fever in the intensive care unit, for the purpose of guiding…”
Get full text

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study by Kohli, Anita, MD, Osinusi, Anuoluwapo, MD, Sims, Zayani, BS, Nelson, Amy, RN, Meissner, Eric G, MD, Barrett, Lisa L, MD, Bon, Dimitra, MS, Marti, Miriam M, BS, Silk, Rachel, RN, Kotb, Colleen, NP, Gross, Chloe, RN, Jolley, Tim A, RN, Sidharthan, Sreetha, BS, Petersen, Tess, BS, Townsend, Kerry, BA, Egerson, D'Andrea, RN, Kapoor, Rama, MD, Spurlin, Emily, BA, Sneller, Michael, MD, Proschan, Michael, PhD, Herrmann, Eva, PhD, Kwan, Richard, PAC, Teferi, Gebeyehu, MD, Talwani, Rohit, MD, Diaz, Gabbie, RN, Kleiner, David E, MD, Wood, Brad J, MD, Chavez, Jose, MD, Abbott, Stephen, MD, Symonds, William T, PharmD, Subramanian, G Mani, MD, Pang, Phillip S, MD, McHutchison, John, MD, Polis, Michael A, MD, Fauci, Anthony S, MD, Masur, Henry, MD, Kottilil, Shyam, Dr

“…Summary Background Direct-acting antiviral drugs have a high cure rate and favourable tolerability for patients with hepatitis C virus (HCV). Shorter courses…”
Get full text

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection by Orr, Cody, Xu, Wenjie, Masur, Henry, Kottilil, Shyam, Meissner, Eric G

“…Treatment of chronic hepatitis C virus infection with direct acting antiviral therapy results in viral elimination in over 90% of cases. The duration of…”
Get full text

Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease by Gnann, Jr, John W, Agrawal, Amy, Hart, John, Buitrago, Martha, Carson, Paul, Hanfelt-Goade, Diane, Tyler, Ken, Spotkov, Jared, Freifeld, Alison, Moore, Thomas, Reyno, Jorge, Masur, Henry, Jester, Penelope, Dale, Ilet, Li, Yufeng, Aban, Inmaculada, Lakeman, Fred D, Whitley, Richard J

“…West Nile Virus (WNV) can result in clinically severe neurologic disease. There is no treatment for WNV infection, but administration of anti-WNV polyclonal…”
Get full text

Highly variable trends in rates of newly diagnosed HIV cases in U.S. hotspots, 2008-2017 by Segarra, Lorena, Simmens, Samuel J, Castel, Amanda D, Kharfen, Michael, Masur, Henry, Greenberg, Alan E

“…The U.S. Ending the HIV Epidemic (EHE) initiative was announced in early 2019 and rapidly became a focal point for domestic HIV prevention and treatment…”
Get full text

CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients by Shrivastava, Shikha, Kottilil, Shyam, Sherman, Kenneth E, Masur, Henry, Tang, Lydia

“…Liver fibrosis is accelerated in patients coinfected with hepatitis C virus and human immunodeficiency virus (HIV), compared with HCV monoinfected patients,…”
Get full text

Guidelines for the Prevention of Intravascular Catheter–Related Infections by O'Grady, Naomi P., Alexander, Mary, Dellinger, E. Patchen, Gerberding, Julie L., Heard, Stephen O., Maki, Dennis G., Masur, Henry, McCormick, Rita D., Mermel, Leonard A., Pearson, Michele L., Raad, Issam I., Randolph, Adrienne, Weinstein, Robert A.

“…These guidelines have been developed for practitioners who insert catheters and for persons responsible for surveillance and control of infections in hospital,…”
Get full text

Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors by Zonios, Dimitrios I., Falloon, Judith, Bennett, John E., Shaw, Pamela A., Chaitt, Doreen, Baseler, Michael W., Adelsberger, Joseph W., Metcalf, Julia A., Polis, Michael A., Kovacs, Stephen J., Kovacs, Joseph A., Davey, Richard T., Lane, H. Clifford, Masur, Henry, Sereti, Irini

“…Idiopathic CD4+ lymphocytopenia (ICL) is a rare non–HIV-related syndrome with unclear natural history and prognosis. This prospective natural history cohort…”
Get full text

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy by Meissner, Eric G, Decalf, Jérémie, Casrouge, Armanda, Masur, Henry, Kottilil, Shyam, Albert, Matthew L, Duffy, Darragh

“…Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy…”
Get full text

Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration by Townsend, Kerry, Meissner, Eric G, Sidharthan, Sreetha, Sampson, Maureen, Remaley, Alan T, Tang, Lydia, Kohli, Anita, Osinusi, Anu, Masur, Henry, Kottilil, Shyam

“…Chronic hepatitis C virus (HCV) infection is associated with lower serum concentration of low-density lipoprotein (LDL-C), the primary cholesterol metabolite…”
Get more information

Guidelines for preventing opportunistic infections among HIV-infected persons-2002: Recommendations of the U.S. public Health Service and the infectious Diseases Society of America by MASUR, Henry, KAPLAN, Jonathan E, HOLMES, King K

“…In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic…”
Get full text

Current epidemiology of Pneumocystis pneumonia by Morris, Alison, Lundgren, Jens D, Masur, Henry, Walzer, Peter D, Hanson, Debra L, Frederick, Toni, Huang, Laurence, Beard, Charles B, Kaplan, Jonathan E

“…Pneumocystis pneumonia (PCP) has historically been one of the leading causes of disease among persons with AIDS. The introduction of highly active…”
Get full text

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study by Petersen, Tess, Townsend, Kerry, Gordon, Lori A., Sidharthan, Sreetha, Silk, Rachel, Nelson, Amy, Gross, Chloe, Calderón, Monica, Proschan, Michael, Osinusi, Anu, Polis, Michael A., Masur, Henry, Kottilil, Shyam, Kohli, Anita

“…Background As treatment for chronic hepatitis C (HCV) virus has evolved to all-oral, interferon-free directly acting antiviral (DAA) therapy, the impact of…”
Get full text

Critical Care of Persons Infected with the Human Immunodeficiency Virus by Ganesan, Anuradha, MBBS, MPH, Masur, Henry, MD

“…Antiretroviral therapy (ART) has transformed the prognosis for patients infected with the human immunodeficiency virus (HIV). With effective ART, these…”
Get full text